About this entry
neolexon Aphasie is a digital health app from Limedix GmbH with a permanent DiGA listing in Germany's DiGA directory (BfArM id 01196). It is indicated for Dysphasie und Aphasie. First listed on 2022-02-06. It moved to permanent status on 2024-02-05. The public prescription price is EUR 223.01 for a 90-day unit. German statutory health insurers reimburse prescribed use under the Digital Healthcare Act rules. This page is not legal or reimbursement advice; confirm the current entry on the official BfArM listing.
- App
- neolexon Aphasie
- Maker
- Limedix GmbH
- Country
- Germany
- Program
- DiGA
- Indication
- Dysphasie und Aphasie
- Status
- Permanent
- Indication detail
- R47.0 Dysphasie und Aphasie; R48.2 Apraxie
- Indication codes
- R47.0, R48.2
- Listing date
- 2022-02-06
- Permanent since
- 2024-02-05
- Public price
- EUR 223.01 per 90-day unit
- BfArM DiGA id
- 01196
Not legal or reimbursement advice. Confirm the current entry with the official source.